§ 22 §2353 — Naloxone hydrochloride or another opioid overdose-reversing medication

Maine § 22 §2353

• Jurisdiction: Maine
• Title 22: HEALTH AND WELFARE
• Part 5: FOODS AND DRUGS
• Ch. 556-A: OPIOIDS

Text

1.
Definitions.
As used in this section, unless the context otherwise indicates, the following terms have the following meanings.
2.
Prescription; possession; administration.
The prescription, possession and administration of naloxone hydrochloride or another opioid overdose-reversing medication is governed by this subsection.
2-A.
Dispensing of naloxone hydrochloride or another opioid overdose-reversing medication by emergency medical services persons, ambulance services and nontransporting emergency medical services.
Notwithstanding any provision of law to the contrary, pursuant to a standing order issued in accordance with protocols developed by the Medical Direction and Practices Board pursuant to Title 32, section 88‑B, subsection 1, paragraph A, an emergency medical services person, ambulance service or nontransporting emergency medical service licensed under Title 32, chapter 2‑B may dispense naloxone hydrochloride or another opioid overdose-reversing medication to an individual of any age at risk of experiencing an opioid-related drug overdose or to a member of the individual's immediate family, a friend of the individual or another person in a position to assist the individual if the individual is at risk of experiencing an opioid-related drug overdose.
3.
Authorized administration and dispensing of naloxone hydrochloride or another opioid overdose-reversing medication by corrections officers and municipal firefighters.
A regional or county jail, a prison, a correctional facility as defined in Title 34‑A, section 1001, subsection 6 or a municipal fire department as defined in Title 30‑A, section 3151, subsection 1 is authorized to obtain a supply of naloxone hydrochloride or another opioid overdose-reversing medication to be administered or dispensed in accordance with this subsection. A corrections officer, in accordance with policies adopted by the jail, prison or correctional facility, and a municipal firefighter as defined in Title 30‑A, section 3151, subsection 2, in accordance with policies adopted by the municipality, may administer or dispense intranasal naloxone hydrochloride or another opioid overdose-reversing medication as clinically indicated if the corrections officer or municipal firefighter has received medical training in accordance with protocols adopted by the Medical Direction and Practices Board established in Title 32, section 83, subsection 16‑B. The Medical Direction and Practices Board shall establish medical training protocols for corrections officers and municipal firefighters pursuant to this subsection.
3-A.
Authorized administration, dispensing and carrying of naloxone hydrochloride by law enforcement officers.
A law enforcement agency as defined in Title 25, section 3701, subsection 1 is authorized to obtain a supply of naloxone hydrochloride to be administered or dispensed in accordance with this subsection. A law enforcement officer as defined in Title 17‑A, section 2, subsection 17, in accordance with policies adopted by the law enforcement agency, may administer or dispense intranasal naloxone hydrochloride as clinically indicated if the law enforcement officer has received medical training in accordance with protocols adopted by the Medical Direction and Practices Board established in Title 32, section 83, subsection 16‑B. A law enforcement officer who performs duties as a uniformed patrol officer, in accordance with policies adopted by the law enforcement agency, shall carry naloxone hydrochloride at all times when on duty, obtain medical training in accordance with protocols adopted by the Medical Direction and Practices Board and administer or dispense intranasal naloxone hydrochloride as clinically indicated. The Medical Direction and Practices Board shall establish medical training protocols for law enforcement officers pursuant to this subsection.
4.
Community-based drug overdose prevention programs; standing orders for naloxone hydrochloride or another opioid overdose-reversing medication.
Acting under standing orders from a licensed health care professional authorized by law to prescribe naloxone hydrochloride or another opioid overdose-reversing medication, an agency that provides services to populations at high risk for a drug overdose may establish an overdose prevention program in accordance with rules adopted by the department and the provisions of this subsection.
4-A.
Recovery residences; standing orders for naloxone hydrochloride or another opioid overdose-reversing medication.
Acting under standing orders from a licensed health care professional authorized by law to prescribe naloxone hydrochloride or another opioid overdose-reversing medication, a recovery residence shall operate in accordance with rules adopted by the department and the provisions of this subsection.
5.
Immunity.
The following provisions provide immunity for actions taken in accordance with this section.

Legislative History

PL 2013, c. 579, §1 (NEW). RR 2015, c. 1, §19 (COR). PL 2015, c. 351, §§1, 2 (AMD). PL 2015, c. 508, §§1-4 (AMD). PL 2017, c. 220, §1 (AMD). PL 2017, c. 249, §1 (AMD). PL 2017, c. 364, §§1-5 (AMD). PL 2017, c. 417, §§1-4 (AMD). PL 2019, c. 292, §§2, 3 (AMD). PL 2021, c. 161, §1 (AMD). PL 2021, c. 605, §§1, 2 (AMD). PL 2023, c. 71, §§1, 2 (AMD). PL 2023, c. 153, §§1, 2 (AMD). PL 2023, c. 153, §3 (AFF). PL 2023, c. 154, §§1, 2 (AMD). PL 2023, c. 161, §3 (AMD). PL 2023, c. 646, Pt. A, §§23, 24 (AMD). PL 2025, c. 145, §§1-6 (AMD).